Article Details
Retrieved on: 2023-11-09 21:41:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(AP) — Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $18 million in its third quarter. On a per-share basis, the Palo Alto, ...
Article found on: qz.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here